Brian Christin is Senior Director, CMC Strategy Lead at GentiBio. Brian has experience advancing multiple cell therapy programs through clinical and commercial development during his time at Dendreon, Juno Therapeutics, Celgene, and Bristol Myers Squibb. Most recently, Brian was the Senior Director of Cell Therapy Product Stewardship at Bristol Myers Squibb (previously Celgene, Juno Therapeutics) where he led a team that maintained technical accountability for approval, launch, and post-approval lifecycle management of the commercial Breyanzi and Abecma programs and supported advancement of multiple early phase cell therapy programs. Born and raised in the Seattle area, Brian stayed in the Pacific Northwest and obtained a BS in Chemical Engineering from the University of Washington (Go Dawgs!). Outside of work, Brian enjoys spending time with his family, catching a Sounders or Kraken game, and exploring Washington wine regions.
Brian Christin, BS
Senior Director, CMC Strategy Lead
